Access to Exclusive Content. FREE for Registered Users Only.
Join the Channelchek Investor Community to access equity research, video content, events, and much more. All at no cost.
Share
Welcome to the Channelchek Investor Community
We’ve updated the entire site to bring you faster navigation and increased content at every level. Channelchek is now North America’s leading platform for access to regulated and independent company sponsored equity research.
By clicking “Log In” you agree to Channelchek.com Terms of Use and acknowledge that Channelchek.com Privacy Policy applies to you.
Related News
10/19/2026
Defense
Release – The GEO Group Completes Redemption of All Senior Secured Notes Due 2029
The GEO Group, Inc. (NYSE: GEO) (“GEO” or the “Company”) announced today that it completed the redemption of all of the $650,000,000 in outstanding aggregate principal amount of its 8.625%Senior...
10/19/2026
Health
Release – NeuroSense Files U.S. Patent Application for Traumatic Brain Injury
NeuroSense Therapeutics Ltd. (NASDAQ: NRSN) (“NeuroSense” or the “Company”), a late-stage clinical biotechnology company developing treatments for neurodegenerative diseases, today announced that it has filed a patent application with the...
10/19/2026
Health
Merck to Acquire Silence Therapeutics for $1.3 Billion in Major Gene-Silencing Biotech Deal
Merck KGaA agrees to acquire Silence Therapeutics (SLN) for $1.3 billion at a 130% premium, expanding its pipeline of gene-silencing treatments.
...
